Stryker Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 02:15PM GMT
Andrew Christopher Ranieri - Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us today at the Morgan Stanley Healthcare Conference, I'm Drew Ranieri, one of the medical device analysts here. From Stryker, I'm really excited to have Kevin Lobo, Chairman and CEO; and Glenn Boehnlein, VP and CFO. Also, Preston Wells is here, Head of IR. They are joining us this morning for a fireside chat.

But before we jump into it, just a housekeeping item. For important disclosures, please see the Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep.

With that, Kevin and Glenn, thank you so much for your time today. Looking forward to the discussion. And so there's clearly a lot to cover today, and I don't think you'll be too surprised with kind of our first topic, considering that's on many folks' mind here.

Questions and Answers:

Andrew Christopher Ranieri - Morgan Stanley, Research Division - Equity Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot